Co‐treatment of non‐steroidal anti‐inflammatory drug‐exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization

Saved in:
Bibliographic Details
Published inClinical and experimental allergy Vol. 53; no. 9; pp. 974 - 977
Main Authors Buchheit, Kathleen M., Hacker, Jonathan, Maurer, Rie, McGill, Alanna, Ryan, Tessa, Bensko, Jillian C., Laidlaw, Tanya M.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.09.2023
Subjects
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Antibodies, Monoclonal, Humanized - adverse effects
Aspirin
Aspirin - adverse effects
aspirin desensitization
aspirin therapy after desensitization
aspirin‐exacerbated respiratory disease
asthma
Asthma, Aspirin-Induced - diagnosis
Asthma, Aspirin-Induced - drug therapy
Chronic Disease
chronic rhinosinusitis
Desensitization, Immunologic
dupilumab
Humans
nasal polyps
Nasal Polyps - drug therapy
NSAID‐exacerbated respiratory disease
Respiratory diseases
Respiratory Tract Diseases - drug therapy
Rhinitis
Rhinitis - drug therapy
Sinusitis
NSAID-exacerbated respiratory disease
aspirin desensitization
aspirin-exacerbated respiratory disease
chronic rhinosinusitis
nasal polyps
aspirin therapy after desensitization
asthma
dupilumab
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
Statement of contribution: KB and TL designed the study. KB, AM, TR, JB, and TL collected the clinical data. JH carried out laboratory assessments. KB, RM, and TL completed data analysis. KB and TL wrote the paper with input from all authors.
ISSN:0954-7894
1365-2222
1365-2222
DOI:10.1111/cea.14348